据港交所1月30日披露，明智科技股份有限公司(简称：明智科技)向港交所主板递交上市申请，建银国际为其独家保荐人。招股书显示，根据灼识咨询的资 料，按2024年出货量计算，明智科技位列美国、欧洲及日本一次性输尿管镜市场前三大品牌。此外，该公司开发了世界上最纤细之一的一次性输尿管镜，及 世界上最纤细之一的膀胱镜(工作通道为6.6Fr)。 公司简介 据招股书，明智科技是一家平台型医疗器械公司，凭借创新可视化与微创医疗器械，在一次性泌尿科内窥镜领域处于领先地位。该公司于硅谷及中国营运， 专注于一次性内窥镜系统的研发和商业化。明智科技是全球极少数成功实现一次性内窥镜供应链垂直整合的公司之一，涵盖从核心光电组件及精密零件的自 主研发制造，到完整系统的组装全过程。 凭借明智科技的自有品牌组合-包括OTU(ONETU )、与顶尖医疗科技公司共同打造的OTU联合品牌，以及WiScope —该公司已开发覆盖泌尿科、肝胆外科、 呼吸科、耳鼻喉科、肠胃科及妇科的全面产品组合。截至最后实际可行日期，明智科技在全球主要市场(包括美国、欧盟及中国)拥有8个已获批产品类别以 及5个在研产品类别。 明智科技的产品组合包括两个主要部分： 1.一 ...

智通财经APP获悉，据港交所1月30日披露，明智科技股份有限公司(简称：明智科技)向港交所主板递交上市申请，建银国际为其独家保荐人。招股书显示， 根据灼识咨询的资料，按2024年出货量计算，明智科技位列美国、欧洲及日本一次性输尿管镜市场前三大品牌。此外，该公司开发了世界上最纤细之一的一 次性输尿管镜，及世界上最纤细之一的膀胱镜(工作通道为6.6Fr)。 公司简介 据招股书，明智科技是一家平台型医疗器械公司，凭借创新可视化与微创医疗器械，在一次性泌尿科内窥镜领域处于领先地位。该公司于硅谷及中国营运， 专注于一次性内窥镜系统的研发和商业化。明智科技是全球极少数成功实现一次性内窥镜供应链垂直整合的公司之一，涵盖从核心光电组件及精密零件的自 主研发制造，到完整系统的组装全过程。 凭借明智科技的自有品牌组合-包括OTU(ONETU)、与顶尖医疗科技公司共同打造的OTU联合品牌，以及WiScope该公司已开发覆盖泌尿科、肝胆外科、呼 吸科、耳鼻喉科、肠胃科及妇科的全面产品组合。截至最后实际可行日期，明智科技在全球主要市场(包括美国、欧盟及中国)拥有8个已获批产品类别以及5 个在研产品类别。 2.图像处理器：兼容资本设备( ...

Core Viewpoint - The announcement highlights that Guangzhou Welly Medical Instrument Co., Ltd.'s subsidiary, Suzhou Medexin Medical Technology Co., Ltd., has received a Class II medical device registration certificate for its image processor, which is expected to enhance the company's market competitiveness in the medical device sector [1][3]. Group 1: Medical Device Registration Details - The registration certificate was issued by the Jiangsu Provincial Drug Administration with the registration number Su Xie Zhu Zheng 20252061723 [1]. - The product, an image processor, consists of a display screen, power adapter, image processing module (available in wired and wireless connections), and accessories including a display holder and hex screws [1][2]. - The approval date for the registration is September 2, 2025, and it is valid until September 1, 2030 [3]. Group 2: Impact on the Company - The image processor is designed to be used in conjunction with the company's visual products for effective display of the camera's observed field during diagnosis and surgery [2][3]. - The acquisition of the medical device registration certificate is anticipated to positively impact the company's operations and enhance the competitiveness of its visual products in the market [3].

Group 1 - The core point of the article is that Weili Medical (603309) announced that its subsidiary, Suzhou Medtronic Medical Technology Co., Ltd., has received a medical device registration certificate from the Jiangsu Provincial Drug Administration for its image processor product [1] Group 2 - The product name registered is "Image Processor" [1] - The announcement was made on the evening of September 4 [1] - The registration certificate is a significant regulatory milestone for the company [1]

Core Viewpoint - Weili Medical (603309.SH) announced that its subsidiary, Suzhou Medtronic Medical Technology Co., Ltd., has received a Class II medical device registration certificate for its image processor product, which enhances the competitiveness of the company's visual products in the market [1]. Group 1 - The product is designed for clinical use in displaying images of the observation field during diagnosis and treatment in human body cavities and surgeries [1]. - The registration certificate was issued by the Jiangsu Provincial Drug Administration, indicating regulatory approval for the product [1]. - The approval is expected to have a positive impact on the company's operations and market position [1].

Core Viewpoint - Weili Medical (603309.SH) announced that its subsidiary, Suzhou Medtronic Medical Technology Co., Ltd., has received the Medical Device Registration Certificate from the Jiangsu Provincial Drug Administration for its image processor product, which enhances the competitiveness of the company's visual products in the market [1] Group 1 - The product is designed for clinical use in conjunction with the company's visual products, effectively displaying images of the observed field during diagnosis and surgery [1] - The acquisition of the medical device registration certificate is expected to have a positive impact on the company's operations [1]

Core Viewpoint - The company, Weili Medical (603309.SH), has received a medical device registration certificate from the Jiangsu Provincial Drug Administration for its image processor product, which is designed for use in conjunction with the company's visual products during diagnostic and surgical procedures [1]. Group 1 - The product is intended to effectively display images of the observed field during diagnosis and treatment within the human body [1]. - The image processor will be utilized in clinical settings alongside the company's existing visual products [1]. - The approval from the regulatory authority enhances the company's product portfolio and potential market offerings in the medical device sector [1].

Group 1 - The company, Weili Medical (603309.SH), announced that its subsidiary, Suzhou Medtronic Medical Technology Co., Ltd. (referred to as "Suzhou Medtronic"), has recently received a Medical Device Registration Certificate from the Jiangsu Provincial Drug Administration [1] - The product named "Image Processor" is designed to be used in conjunction with the company's and its subsidiaries' visual products for effective display of the imaging area observed by the camera during diagnosis and treatment in human body cavities and surgeries [1]